Perichondritis of external ear

H8_PERCHRONDR

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H61.0
  • Hospital discharge: ICD-9 3800
  • Hospital discharge: ICD-8 38798
  • Cause of death: ICD-10 H61.0
  • Cause of death: ICD-9 3800
  • Cause of death: ICD-8 38798

2 out of 7 registries used, show all original rules.

626

4. Check minimum number of events

None

626

5. Include endpoints

None

626

6. Filter based on genotype QC (FinnGen only)

626

Control definitions (FinnGen only)

Control exclude
H8_EXTERNAL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H61
Name in latin
Perichondritis auris externae

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4952 2479 2432
Only index persons 4192 2180 2012
Unadjusted period prevalence (%)
Whole population 0.07 0.07 0.07
Only index persons 0.08 0.08 0.08
Median age at first event (years)
Whole population 49.13 53.02 45.11
Only index persons 47.52 51.82 42.85

-FinnGen-

Key figures

All Female Male
Number of individuals 626 336 290
Unadjusted period prevalence (%) 0.12 0.11 0.13
Median age at first event (years) 48.05 50.20 45.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
548
Matched controls
5479
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H61.0
ICD-10 Finland
Perichondritis of external ear
+∞
323.0
286
*
38798
ICD-8 Finland
Other disease of ear and mastoid process, Alii definiti
+∞
257.1
226
*
3800A
ICD-9 Finland
Disorders of external ear, Perichondritis of pinna
+∞
43.3
41
*
DAB00
NOMESCO Finland
Excision of lesion of auricle
22.0
26.9
39
19
H61.8
ICD-10 Finland
Other specified disorders of external ear
98.2
17.7
19
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.4
16.8
88
293
J01DA01
ATC
[U] cefalexin; systemic
2.2
16.2
365
2627
H62.0*A46
ICD-10 Finland
Otitis externa in erysipelas
153.9
14.5
15
*
H60.9
ICD-10 Finland
Otitis externa, unspecified
5.2
14.4
45
93
TDA10
NOMESCO Finland
Needle biopsy of auricle or external auditory canal
143.3
13.5
14
*
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
14.5
12.8
21
15
H61.2
ICD-10 Finland
Impacted cerumen
4.1
10.8
42
109
4141
FHL
Myringoplasty (also for reasons other than inflammation)
22.0
10.7
15
7
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.2
10.5
118
604
H60.1
ICD-10 Finland
Cellulitis of external ear
12.4
10.4
18
15
L57.0
ICD-10 Finland
Actinic keratosis
2.6
10.2
79
335
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.6
9.4
69
285
SPAT1153
SPAT
Removal of sutures
1.8
9.0
186
1200
H29
ICPC
Ear symptom/complaint other
2.5
8.5
69
300
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.5
8.2
37
111
H60.8
ICD-10 Finland
Other otitis externa
7.0
8.1
19
28
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
4.2
8.0
29
72
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
6.2
7.9
20
33
H71
ICD-10 Finland
Cholesteatoma of middle ear
11.0
7.8
14
13
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
5.7
7.7
21
38
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
15.3
7.7
12
8
UDC00
NOMESCO Finland
Ear microscopy
2.7
7.7
50
193
H60.3
ICD-10 Finland
Other infective otitis externa
12.1
7.6
13
11
M94.1
ICD-10 Finland
Relapsing polychondritis
81.1
7.4
8
*
J01DB01
ATC
cefalexin; oral
1.8
7.3
424
3622
A46
ICD-10 Finland
Erysipelas
2.1
7.2
90
479
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.1
7.1
83
428
SPAT1301
SPAT
No procedures
1.7
7.0
183
1251
E0000UV
ATC
NA
1.7
6.8
200
1414
H62.0
ICD-10 Finland
Otitis externa in bacterial diseases classified elsewhere
40.5
6.8
8
*
J01FF01
ATC
clindamycin; systemic
1.8
6.7
143
916
E000001
ATC
NA
1.9
6.7
112
667
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
6.6
49
204
SPAT1263
SPAT
Sampling
1.6
6.6
225
1649
H01
ICPC
Ear pain/earache
2.4
6.5
54
237
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
6.5
144
937
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
6.5
123
761
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.1
6.4
74
381
SPAT1254
SPAT
Administration of medicine
1.9
6.2
88
494
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
6.2
86
479
J01MA02
ATC
ciprofloxacin; systemic
1.6
6.1
210
1535
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
6.1
59
281
S02CA02
ATC
flumetasone and antiinfectives; otic
2.6
6.1
41
164
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.8
6.1
24
66
H92.0
ICD-10 Finland
Otalgia
3.2
6.0
29
93

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019060) Gas panel - Arterial blood
87
381
2.49
12.61
5.0
4.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
78
350
2.40
10.68
8.0
6.6
mmol/l
25.0
24.2
0.98
73
329
(3003396) Base excess in Arterial blood by calculation
113
631
1.97
8.86
6.2
6.5
mmol/l
2.3
1.3
1.61
90
487
(3027801) Oxygen [Partial pressure] in Arterial blood
113
637
1.94
8.61
6.2
6.4
kpa
11.2
12.0
1.18
108
610
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
113
637
1.94
8.61
6.2
6.4
kpa
5.3
5.1
0.75
107
607
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
145
893
1.81
8.37
2.1
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
234
1668
1.64
7.87
7.2
5.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
267
1969
1.62
7.82
2.4
2.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
335
2619
1.60
7.63
7.8
6.4
mmol/l
1.2
1.2
1.45
294
2214
(3019150) Specific gravity of Urine by Refractometry
171
1138
1.69
7.43
5.1
4.5
kg/l
1.0
1.0
0.09
25
152
(3042936) Bacteria identified in Isolate by Culture
123
754
1.79
7.12
2.4
1.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
310
2407
1.57
7.08
6.5
5.5
mmol/l
1.2
1.2
2.57
286
2172
(3023368) Bacteria identified in Blood by Culture
209
1493
1.60
6.76
5.0
4.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
102
606
1.82
6.53
2.3
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
221
1618
1.57
6.36
2.3
2.1
u/l
151.3
297.6
1.58
209
1522
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
104
635
1.76
6.06
2.0
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
432
3696
1.54
5.82
5.4
4.2
mm/h
14.4
13.2
0.88
402
3393
(3001122) Ferritin [Mass/volume] in Serum or Plasma
268
2083
1.50
5.70
2.8
2.7
ug/l
152.1
141.2
0.23
235
1906
(3024561) Albumin [Mass/volume] in Serum or Plasma
287
2274
1.48
5.49
6.3
4.5
g/l
34.5
35.1
0.90
269
2115
(3037522) Nuclear Ab [Titer] in Serum
100
623
1.72
5.41
1.4
1.3
titre
430.0
469.4
0.12
24
132
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
100
630
1.70
5.19
2.0
1.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
307
2490
1.46
5.08
6.9
5.5
e9/l
0.0
0.0
0.41
280
2153
(3032080) INR in Blood by Coagulation assay
274
2179
1.46
5.01
12.0
10.1
inr
1.2
1.3
0.27
53
615
(3013826) Glucose [Moles/volume] in Serum or Plasma
361
3029
1.45
4.94
5.8
4.5
mmol/l
6.7
6.7
0.10
338
2834
(3013115) Eosinophils [#/volume] in Blood
314
2569
1.45
4.90
7.2
5.7
e9/l
0.2
0.2
0.64
287
2250
(3006504) Eosinophils/100 leukocytes in Blood
288
2320
1.45
4.88
7.5
5.6
%
2.8
2.8
0.08
274
2160
(3001604) Monocytes [#/volume] in Blood
304
2478
1.44
4.81
6.8
5.5
e9/l
0.6
0.6
0.41
276
2138
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
67
384
1.83
4.81
1.7
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
289
2334
1.44
4.81
8.1
5.9
%
8.6
8.7
0.25
273
2185
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
181
1337
1.50
4.76
2.5
2.2
mg/l
3.0
3.2
0.48
154
1133
(3000494) Fungus identified in Specimen by Culture
94
596
1.68
4.76
1.7
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
309
2532
1.44
4.72
7.2
5.5
e9/l
2.1
1.9
0.59
279
2223
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
329
2728
1.43
4.71
6.6
6.1
umol/l
11.1
11.4
0.16
312
2580
(3019309) Folate [Moles/volume] in Red Blood Cells
150
1069
1.53
4.67
2.0
1.8
nmol/l
1275.6
1179.6
0.61
119
801
(3035350) Ketones [Presence] in Urine by Test strip
302
2477
1.42
4.53
4.6
4.0
estimate
0.0
0.0
0.00
42
472
(3026493) Urate [Moles/volume] in Serum or Plasma
178
1323
1.48
4.51
3.3
2.7
umol/l
9278.9
7426.6
0.15
150
1128
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
51
273
1.95
4.51
8.1
8.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
344
2896
1.42
4.41
11.4
9.0
e9/l
4.4
4.1
1.14
312
2528
(3022096) Basophils/100 leukocytes in Blood
278
2257
1.42
4.36
7.5
5.6
%
0.7
0.7
0.56
264
2106
(3036481) Cortisol [Moles/volume] in Serum or Plasma
76
466
1.72
4.35
1.8
1.9
nmol/l
373.3
376.3
0.04
68
429
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
89
2.64
4.35
1.4
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
257
2060
1.42
4.33
2.5
2.3
nmol/l
76.8
78.3
0.34
227
1829
(3018010) Neutrophils/100 leukocytes in Blood
286
2339
1.41
4.28
7.9
5.5
%
57.8
57.9
0.08
269
2191
(3002030) Lymphocytes/100 leukocytes in Blood
290
2378
1.41
4.27
8.1
5.8
%
27.7
27.0
0.42
275
2212
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
79
2.72
4.19
1.4
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
138
992
1.50
4.08
5.0
4.1
ng/l
106.1
218.4
1.22
116
816
(40768797) Stomach Pathology biopsy report
104
703
1.57
4.07
1.3
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
268
2184
1.40
4.02
2.3
2.1
pmol/l
94.2
93.6
0.07
148
1137
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
19
71
2.73
3.85
1.3
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
214
1692
1.40
3.79
3.6
3.0
ng/l
1359.7
1626.6
0.48
186
1443
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
440
3918
1.41
3.78
9.2
7.5
u/l
80.5
79.0
0.25
415
3677
(3021960) Folate [Moles/volume] in Serum or Plasma
171
1300
1.43
3.77
1.7
1.6
nmol/l
20.8
20.7
0.02
156
1102
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
252
2049
1.38
3.77
4.9
3.9
ng/l
44.5
56.8
0.26
189
1507
(3009261) Glucose [Presence] in Urine by Test strip
300
2511
1.37
3.75
4.7
4.0
estimate
0.0
0.0
0.50
42
452
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
111
777
1.52
3.71
1.3
1.3
u/ml
7.5
12.5
0.55
32
284
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
212
1.95
3.67
2.6
2.3
g/l
7.6
7.4
0.14
25
159
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
212
1.95
3.67
2.6
2.3
g/l
3.7
3.7
0.02
23
154
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
212
1.95
3.67
2.6
2.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
198
1.98
3.66
2.7
2.4
g/l
3.4
3.2
0.28
23
157
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
199
1568
1.39
3.55
3.6
3.1
u/l
37.3
33.1
0.33
185
1501
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
203
1606
1.39
3.54
3.3
2.3
u/l
60.8
56.4
0.53
193
1486
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
91
619
1.55
3.46
4.1
3.9
u/l
253.7
261.8
0.18
84
583
(3018677) aPTT in Platelet poor plasma by Coagulation assay
114
819
1.48
3.35
3.1
1.8
s
29.5
29.7
0.14
109
790
(44806118)
15
54
2.82
3.27
1.8
1.5
—
—
—
0
0
(44790049)
15
54
2.82
3.27
1.8
1.5
—
—
—
0
0
(44790048)
15
54
2.82
3.27
1.8
1.5
—
—
—
0
0
(44790047)
15
54
2.82
3.27
1.8
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
113
818
1.47
3.20
1.3
1.3
iu/ml
38.7
39.6
0.02
39
260
(3018405) Lactate [Moles/volume] in Arterial blood
38
209
1.87
3.16
5.9
3.9
mmol/l
1.2
1.4
0.56
38
204
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
118
2.17
3.14
2.2
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
292
2480
1.33
3.13
6.2
5.4
estimate
0.0
0.0
0.00
42
466
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
528
4918
1.47
3.08
22.7
15.4
mg/l
26.5
24.7
0.55
452
3965
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
197
1.88
3.04
2.7
2.4
g/l
11.6
10.1
0.58
25
170
(3018418) pH of Serum or Plasma
200
1611
1.35
3.04
3.5
3.7
ph
7.4
7.4
0.46
24
296
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
144
1101
1.40
3.02
1.8
1.7
mg/l
1.5
1.2
0.33
117
854
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
72
482
1.56
2.95
2.8
2.5
ug/l
4.2
6.4
1.28
64
431
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
17
70
2.47
2.90
1.4
2.8
u/ml
—
854.5
—
0
6
(3017732) Neutrophils [#/volume] in Blood
51
316
1.67
2.86
2.5
2.9
e9/l
4.1
3.9
0.19
37
236
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
71
2.43
2.82
1.2
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
125
2.04
2.74
2.1
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
38
220
1.77
2.71
1.3
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
54
346
1.61
2.67
2.5
2.2
nmol/l
13.0
13.3
0.10
45
306
(3044889) 12 lead EKG panel
396
3557
1.31
2.66
4.8
4.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
43
2.83
2.66
1.0
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
91
655
1.46
2.65
10.5
8.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
66
445
1.54
2.63
3.4
3.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
43
261
1.70
2.62
3.2
2.8
pmol/l
4.3
4.5
0.71
38
221
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
33
186
1.82
2.58
1.6
2.6
g/l
0.8
0.9
0.09
28
160
(3004588) Protein electrophoresis panel - Serum or Plasma
60
398
1.56
2.58
4.2
2.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
71
489
1.51
2.58
1.4
1.6
%
1.5
1.5
0.01
58
413
(3037467) Urinalysis macro (dipstick) panel - Urine
388
3484
1.30
2.57
5.9
4.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
204
1686
1.31
2.53
3.8
3.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
158
1260
1.34
2.52
7.1
6.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
63
425
1.54
2.52
4.4
4.1
%
1.0
0.9
0.07
26
143
(3012095) Magnesium [Moles/volume] in Serum or Plasma
108
811
1.40
2.50
2.9
3.2
mmol/l
0.8
0.8
0.06
103
752
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
36
212
1.74
2.45
2.1
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
230
1940
1.29
2.44
5.2
4.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
34
2.97
2.42
5.0
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
64
2.38
2.40
2.3
4.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
541
5116
1.42
2.39
24.9
18.0
mmol/l
139.6
139.6
0.09
534
4989
(3023103) Potassium [Moles/volume] in Serum or Plasma
542
5129
1.42
2.36
24.8
18.1
mmol/l
4.0
4.0
0.01
535
4996
(3015377) Calcium [Moles/volume] in Serum or Plasma
214
1797
1.29
2.33
3.6
3.4
mmol/l
2.3
2.3
1.24
195
1545
(3002179) Metamyelocytes/100 leukocytes in Blood
57
383
1.54
2.33
4.1
4.0
%
0.7
0.4
0.43
22
103
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
65
2.34
2.33
1.3
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
45
287
1.61
2.29
2.6
2.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
270
2339
1.27
2.28
4.8
4.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
23
3.51
2.27
2.0
3.5
u/ml
1113.6
916.0
—
8
23
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
33
194
1.74
2.27
1.8
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
66
2.30
2.26
1.3
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
66
2.30
2.26
1.3
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
24
128
1.91
2.24
7.4
3.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
29
3.13
2.23
1.2
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
146
1171
1.32
2.22
4.5
4.0
—
—
—
0
0
(3019225) pH of Specimen
71
505
1.46
2.22
5.8
4.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
408
3724
1.27
2.19
4.9
3.9
pmol/l
15.1
14.9
0.47
369
3353
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
348
3125
1.26
2.11
3.7
3.0
u/l
56.1
50.5
0.52
327
2900
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
44
287
1.57
2.07
1.1
1.2
iu/ml
205.6
132.7
0.47
20
106
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
69
2.20
2.06
1.3
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
15
4.03
2.04
1.2
1.9
ug/l
57.4
70.1
—
6
15
(40761511) CBC panel - Blood by Automated count
535
5079
1.37
2.04
22.3
14.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
93
708
1.37
2.00
38.9
26.1
inr
1.8
1.3
—
9
82
(3037756) Immunofixation for Serum or Plasma
22
120
1.86
1.95
2.8
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
77
571
1.40
1.94
2.8
2.4
umol/l
11.2
8.5
0.45
67
497
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
7
22
3.21
1.88
1.4
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
29
175
1.69
1.86
1.3
2.4
g/l
37.6
36.9
0.24
23
149
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
19
101
1.91
1.82
1.6
1.3
—
—
—
0
0
(3020891) Body temperature
35
224
1.60
1.80
7.3
4.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
29
2.78
1.79
1.3
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
478
4499
1.26
1.72
5.9
4.7
mu/l
2.0
1.9
0.41
439
4072
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
21
118
1.81
1.72
1.5
1.7
nmol/l
43.7
42.2
0.07
21
113
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
137
1131
1.27
1.66
2.0
1.8
pmol/l
397.1
12567569.1
0.80
110
931
(3012544) pH of Venous blood
69
517
1.38
1.65
3.9
3.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
25
2.82
1.65
1.6
2.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
56
2.17
1.62
3.0
2.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
14
3.59
1.62
1.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
14
3.59
1.62
1.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
14
3.59
1.62
1.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
14
3.59
1.62
1.0
1.2
—
—
—
0
0
(4062490)
10
43
2.35
1.61
1.3
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
163
1381
1.24
1.58
5.5
4.3
estimate
0.0
0.0
0.69
39
449
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
26
2.71
1.58
1.1
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
26
2.71
1.58
1.1
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
82
642
1.32
1.49
2.4
2.5
%
1.8
1.8
0.02
71
574
(36660697) Celiac disease serology panel - Serum
49
353
1.42
1.49
1.2
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
28
179
1.59
1.48
6.6
3.3
mg/l
45.5
97.4
0.78
23
142
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
52
2.14
1.45
3.2
2.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
66
1.99
1.44
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
66
1.99
1.44
1.3
1.5
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
22
2.74
1.43
11.2
16.4
nmol/l
1217.3
1644.8
—
6
22
(3012516) Albumin [Mass/volume] in Urine
177
1528
1.22
1.43
3.8
3.2
mg/l
2355.2
270.4
1.76
119
972
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
39
2.33
1.43
1.3
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
62
470
1.35
1.41
2.6
2.8
e9/l
68.3
69.6
0.10
52
376
(4010399)
51
375
1.39
1.39
1.5
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
67
1.96
1.39
1.3
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
54
402
1.38
1.37
4.5
4.2
%
0.1
0.1
0.03
22
131
(3000093) Morphology [Interpretation] in Blood Narrative
9
42
2.16
1.34
1.1
1.2
—
—
—
0
0
(4024509)
9
42
2.16
1.34
1.7
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
38
267
1.45
1.33
4.8
3.2
mmol/l
25.3
25.0
0.26
38
262
(3026389) Candida sp identified in Specimen by Organism specific culture
12
61
1.99
1.33
1.6
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
54
2.06
1.33
1.2
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
28
185
1.54
1.31
2.5
3.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
51
380
1.37
1.30
4.8
4.2
%
0.0
0.9
0.53
21
112
(3017704) Immunofixation for Urine
8
34
2.37
1.29
3.0
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
321
1.40
1.27
1.5
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
37
262
1.44
1.26
1.6
1.9
g/l
1.6
1.6
0.08
32
233
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
27
179
1.53
1.25
6.8
3.3
mg/l
41.0
28.7
0.89
22
144
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
147
1.59
1.24
1.2
1.4
ug/g
283.6
281.7
0.02
14
87
(3007461) Platelets [#/volume] in Blood
557
5394
1.30
1.24
32.7
22.7
e9/l
249.4
246.5
0.44
550
5259
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
37
263
1.43
1.24
5.1
3.5
%
49.8
49.6
0.02
37
258
(3010813) Leukocytes [#/volume] in Blood
557
5396
1.29
1.22
32.5
22.7
e9/l
7.2
6.8
1.82
545
5243
(3026361) Erythrocytes [#/volume] in Blood
557
5396
1.29
1.22
32.6
22.7
e12/l
4.4
4.4
3.07
546
5244
(3002032) Base excess in Venous blood by calculation
64
500
1.31
1.21
4.0
3.4
mmol/l
2.8
1.9
1.04
52
396
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
540
5214
1.26
1.20
13.8
10.7
u/l
25.1
25.7
0.37
523
5024
(3000963) Hemoglobin [Mass/volume] in Blood
557
5398
1.29
1.20
32.7
22.8
g/l
131.9
134.0
2.66
552
5312
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
109
1.67
1.20
1.7
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
26
2.32
1.19
1.5
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
26
2.32
1.19
2.5
2.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
12
64
1.89
1.18
1.2
1.3
nmol/l
0.5
0.6
0.21
12
59
(3045414) Leukocytes [Presence] in Urine
30
207
1.47
1.17
2.0
1.9
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
17
102
1.69
1.17
2.9
1.4
nmol/l
0.7
0.9
0.39
11
86
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
8
39
2.06
1.15
1.0
1.6
—
241.4
—
0
7
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
20
2.51
1.15
2.4
5.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
59
461
1.31
1.13
2.7
2.4
u/l
32.3
32.0
0.04
53
389
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
30
2.35
1.12
1.4
1.4
g/l
0.9
1.0
—
7
30
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
7
30
2.35
1.12
1.6
2.0
e9/l
0.3
0.2
—
7
25
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
88
1.72
1.12
2.4
2.9
e9/l
3.5
4.6
0.92
15
88
(3021447) Carbon dioxide [Partial pressure] in Venous blood
64
507
1.29
1.11
4.0
3.4
kpa
5.9
5.8
0.16
64
492
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
211
1.44
1.08
1.1
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
92
765
1.24
1.07
2.6
2.4
g/l
2.5
2.3
2.61
86
708
(3022948) Iron [Moles/volume] in Serum or Plasma
100
840
1.23
1.06
2.6
2.4
umol/l
11.5
12.6
0.90
92
770
(3007164) IgA [Mass/volume] in Serum or Plasma
107
906
1.22
1.05
1.8
1.5
g/l
2.3
2.5
0.40
60
544
(3035637) Corticotropin [Mass/volume] in Plasma
9
46
1.97
1.04
1.7
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
60
1.85
1.03
1.2
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
53
1.90
1.01
2.7
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
53
1.90
1.01
2.7
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
53
1.90
1.01
2.7
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
211
1904
1.16
1.01
3.5
3.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
91
1.66
1.01
2.5
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
118
1014
1.20
1.00
1.3
1.2
u/ml
0.8
1.5
1.30
28
269
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
81
670
1.24
1.00
1.6
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
173
1.46
0.99
1.4
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
73
599
1.25
0.97
1.5
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
141
1.51
0.96
2.0
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
85
1.66
0.95
1.4
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
93
1.63
0.94
2.5
3.3
%
55.4
59.4
0.48
15
93
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
292
2709
1.15
0.94
2.7
2.8
—
—
—
0
0
(3013512) EKG study
173
1546
1.16
0.94
4.7
4.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
160
1.45
0.90
1.6
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
155
1378
1.17
0.90
4.7
4.5
%
21.5
21.5
0.00
81
691
(3005322) IgE [Units/volume] in Serum or Plasma
36
272
1.34
0.89
1.3
1.2
u/ml
324.8
262.7
0.12
31
248
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
86
726
1.21
0.89
2.7
2.4
%
20.0
22.1
0.66
59
613
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
119
1.53
0.89
1.4
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
177
1591
1.16
0.89
3.4
3.1
mmol/l
7.3
7.2
0.04
161
1329
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
64
1.73
0.86
1.0
1.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
8
44
1.83
0.86
1.5
1.4
u/l
20.2
26.3
—
8
36
(3024354) Oxygen [Partial pressure] in Venous blood
54
436
1.26
0.84
3.7
2.7
kpa
4.1
4.4
0.68
54
418
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
129
1.49
0.84
1.6
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
151
1348
1.16
0.83
4.5
3.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
65
1.70
0.82
1.7
2.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
81
1.62
0.81
3.7
2.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
40
313
1.30
0.80
4.3
3.6
mmol/l
2.2
1.8
0.17
30
230
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
58
1.74
0.80
1.2
1.3
nmol/l
—
—
—
0
0
(3022621) pH of Urine by Test strip
43
340
1.28
0.80
4.5
3.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
35
269
1.32
0.79
2.9
2.3
%
0.7
0.7
0.35
35
260
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
18
123
1.48
0.78
1.4
1.7
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
34
1.77
0.76
1.2
2.3
%
13.8
13.3
—
6
34
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
141
1570
0.87
0.76
3.1
3.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
92
1.53
0.73
2.0
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
56
1.62
0.72
1.2
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
60
1.68
0.72
1.4
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
7
40
1.76
0.71
1.1
1.2
nmol/l
350.0
369.4
—
7
35
(3006653) Thiamine [Moles/volume] in Blood
5
26
1.93
0.70
1.4
1.3
nmol/l
149.4
134.4
—
5
26
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
146
0.61
0.70
1.9
1.9
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
118
1.45
0.70
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
118
1.45
0.70
1.5
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
31
396
0.77
0.69
2.1
2.9
ml/min/173m2
57.4
63.5
0.53
14
155
(40768806) Pleura Pathology biopsy report
11
69
1.60
0.68
1.3
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
16
111
1.45
0.66
4.5
4.6
mmol/l
3.2
3.0
—
9
79
(1002224) Polysomnography panel
24
180
1.35
0.66
1.1
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
175
1604
1.13
0.66
2.8
2.4
—
—
—
0
0
(3002256) Pathology report gross observation
74
638
1.18
0.64
1.4
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
65
555
1.19
0.63
2.4
2.2
ug/g
110.3
140.2
0.70
47
437
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
19
138
1.39
0.63
2.0
2.4
ug/min
13.4
69.7
—
10
78
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
474
4598
1.13
0.62
7.2
6.1
mmol/mol
40.7
40.3
0.38
448
4248
(3001019) Free T4 and TSH panel - Serum or Plasma
12
175
0.68
0.61
1.3
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
176
1621
1.12
0.61
4.3
4.0
mg/mmol
4.7
8.5
1.69
119
1034
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(44806420)
0
22
0.00
0.59
0.0
2.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
114
1.41
0.59
1.2
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
64
1.57
0.59
1.1
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
53
1.52
0.58
1.4
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
89
0.56
0.56
1.2
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
113
1249
0.88
0.56
1.3
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
72
629
1.16
0.55
1.9
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
33
267
1.25
0.55
4.1
4.0
—
—
—
0
0
(3000492) Spirometry study
52
442
1.19
0.55
1.4
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
64
555
1.17
0.54
1.5
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
39
1.54
0.53
1.3
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
39
1.54
0.53
1.3
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
118
1071
1.13
0.53
5.5
4.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
100
0.60
0.52
2.2
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
41
487
0.83
0.51
1.5
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
75
1.48
0.51
1.5
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
6
41
1.47
0.50
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
20
154
1.31
0.49
1.7
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
51
439
1.18
0.48
5.8
7.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
492
4808
1.11
0.47
5.3
4.8
mmol/l
6.0
6.0
0.28
457
4346
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
14
102
1.38
0.47
1.4
1.3
e6/l
2.1
13.0
—
9
76
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
111
1.36
0.47
2.3
1.5
iu/l
7.7
6.3
—
6
31
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
40
338
1.20
0.46
1.6
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
94
1.39
0.46
1.7
2.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
51
1.38
0.44
5.9
2.3
—
—
—
0
0
(4146454)
7
51
1.38
0.44
3.1
2.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
52
453
1.16
0.43
1.7
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
113
1.34
0.43
2.1
2.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
131
1.31
0.42
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
29
348
0.83
0.42
1.4
1.4
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
5
32
1.57
0.42
3.0
2.1
ug/l
3.0
2.5
—
5
27
(3021879) Hepatitis B virus core Ab [Presence] in Serum
35
296
1.19
0.41
1.3
1.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
5
33
1.52
0.41
2.6
2.0
ug/l
6.8
4.1
—
5
28
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.1
—
0.7
—
0
7
(3044007) Cell count panel - Peritoneal fluid
0
16
0.00
0.41
0.0
2.2
—
—
—
0
0
(4034850)
20
159
1.27
0.40
28.9
10.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
114
1051
1.10
0.40
3.6
3.2
mmol/l
2.5
2.5
0.07
99
917
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
1.6
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
35
1.43
0.39
3.2
3.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
59
524
1.14
0.39
1.7
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
280
1.19
0.38
1.3
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
13
98
1.33
0.37
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
111
0.72
0.37
1.3
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
31
263
1.19
0.36
1.3
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
20
162
1.24
0.36
2.3
1.8
mg/l
1.8
2.9
0.88
13
119
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
76
0.66
0.36
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
87
0.69
0.33
1.0
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
139
1308
1.08
0.32
1.8
1.7
mmol/l
1.4
1.4
0.15
119
1086
(3045424) Erythrocytes [Presence] in Urine
10
74
1.36
0.32
1.5
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
132
0.75
0.32
1.2
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
47
1.28
0.32
2.0
1.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
7
52
1.35
0.31
1.0
1.1
g/l
1.5
1.5
—
7
47
(3022313) Gas panel - Capillary blood
29
249
1.17
0.31
4.9
3.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
97
0.72
0.31
1.3
2.0
%
61.5
57.8
—
7
97
(3003327) Ova and parasites identified in Stool by Light microscopy
17
138
1.24
0.30
1.8
1.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
7
54
1.30
0.30
1.1
1.5
mosm/kgh2o
275.9
274.8
—
7
40
(3051611) Lipemic interference index of Serum or Plasma
7
54
1.30
0.30
4.3
3.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
153
1612
0.93
0.30
3.7
3.3
e6/l
36.5
116.3
1.14
124
1243
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
57
1.23
0.29
4.1
3.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
38
428
0.88
0.28
5.5
3.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
333
0.86
0.28
2.0
1.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
22
186
1.19
0.28
3.0
3.3
g/l
0.2
0.2
—
7
70
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
128
1211
1.07
0.27
2.5
2.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
171
0.81
0.26
1.0
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
72
0.69
0.26
1.2
2.1
pg
32.4
32.7
—
5
72
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
489
4819
1.07
0.26
5.1
4.5
mmol/l
4.5
4.6
1.27
457
4426
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
142
1.20
0.25
1.8
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
96
903
1.07
0.24
2.8
2.8
e6/l
1.2
1.1
0.15
62
515
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
46
418
1.11
0.24
3.8
3.7
ng/l
98.6
85.9
0.39
39
369
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
18
152
1.19
0.24
1.8
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
115
1.22
0.23
1.2
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
106
1.23
0.23
4.4
3.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
38
1.32
0.23
1.6
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
500
4937
1.06
0.23
5.7
5.1
mmol/l
2.6
2.7
1.82
468
4501
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
177
1702
1.06
0.23
5.2
5.1
ug/l
3.1
2.7
0.33
156
1520
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
168
0.83
0.23
1.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
135
0.81
0.22
1.0
1.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
5
41
1.22
0.22
1.2
1.1
—
2.7
—
0
8
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
167
0.83
0.22
1.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
123
0.81
0.20
1.2
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
14
0.00
0.20
0.0
1.1
—
2.4
—
0
14
(3026782) Osmolality of Urine
110
1048
1.06
0.20
3.3
2.9
mosm/kgh2o
570.5
555.0
0.31
93
895
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
53
1.13
0.18
2.0
2.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
109
1.20
0.18
1.4
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
58
1.21
0.18
1.6
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
185
1.14
0.18
3.0
2.6
u/ml
0.4
0.4
0.33
13
104
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
468
4625
1.05
0.18
4.4
4.0
mmol/l
1.4
1.3
2.03
433
4195
(3052851) Hemolysis interference index of Serum or Plasma
17
148
1.15
0.17
3.5
3.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
69
0.72
0.17
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
69
1.16
0.16
1.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
37
341
1.09
0.16
2.5
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
484
4791
1.05
0.16
4.8
4.5
mmol/l
1.4
1.5
0.72
450
4373
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
72
1.11
0.16
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
83
1.21
0.15
1.2
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
83
1.21
0.15
1.2
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
41
440
0.93
0.15
3.8
3.4
mmol/l
1.2
1.2
0.37
33
382
(1761482) Bacteria [#/volume] in Urine by Culture
17
151
1.13
0.13
5.6
5.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
465
4606
1.04
0.13
16.8
14.5
ml/min/173m2
77.1
77.0
0.02
392
3816
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
33
306
1.08
0.13
2.7
1.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
61
580
1.06
0.13
3.7
4.1
ug/l
12.4
32.5
0.69
51
495
(3008898) HLA-B27 [Presence]
13
148
0.88
0.12
1.5
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
85
1.18
0.12
1.8
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
439
4351
1.03
0.11
23.6
16.7
%
39.1
39.4
0.32
275
2951
(3000764) Benzodiazepines [Presence] in Urine
13
115
1.13
0.10
1.4
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
249
0.92
0.10
1.1
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
29
271
1.07
0.10
1.7
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
30
320
0.93
0.10
1.4
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
45
1.11
0.10
2.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
46
1.09
0.09
1.6
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
46
1.09
0.09
1.4
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
47
1.06
0.09
3.8
2.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
116
1.12
0.09
1.4
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
116
1.12
0.09
1.4
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
48
1.04
0.09
1.4
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
48
1.04
0.09
1.6
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
97
997
0.97
0.08
3.3
3.0
ug/l
0.7
0.8
0.64
68
666
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
1.3
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
12
107
1.12
0.08
2.7
2.8
umol/l
27.3
32.8
—
7
83
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
19
175
1.09
0.08
1.2
1.3
g/l
1.3
1.2
0.99
19
167
(4035726)
46
440
1.05
0.08
1.4
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
226
0.93
0.08
1.8
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
13
117
1.11
0.08
1.4
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
64
1.09
0.08
1.9
1.6
—
—
—
0
0
(4306422)
7
64
1.09
0.08
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
20
215
0.93
0.07
2.8
2.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
75
1.07
0.07
1.0
1.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
13
118
1.10
0.07
1.7
2.5
kpa
7.4
7.8
0.76
13
105
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
86
1.05
0.07
1.3
1.2
—
—
—
0
0
(4094501)
11
122
0.90
0.07
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
89
1.13
0.07
1.6
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
91
0.88
0.07
4.8
2.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
162
0.92
0.06
1.5
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
119
1.09
0.06
1.2
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
139
1412
0.98
0.06
3.4
3.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
66
643
1.03
0.05
4.8
4.5
%
32.8
32.3
0.12
50
430
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
56
544
1.03
0.05
5.3
3.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
120
0.92
0.05
1.9
2.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
91
1.10
0.04
1.4
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
113
1114
1.02
0.04
2.9
2.6
e6/l
6.1
5.6
0.11
96
971
(3021589) Normoblasts [#/volume] in Blood
220
2192
1.01
0.01
10.8
9.4
e9/l
0.0
0.0
0.51
191
1787
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
106
0.94
0.01
1.2
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
13
132
0.98
0.00
1.0
1.1
—
13.6
—
0
14
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
17
168
1.01
0.00
1.2
1.3
g/l
0.3
0.2
1.37
17
160
(3018095) Leukocytes [#/volume] in Urine
185
1855
1.00
0.00
4.0
3.8
e6/l
83.3
163.7
0.83
141
1323
(3030467) Casts [#/volume] in Urine by Automated count
147
1467
1.00
0.00
3.4
3.2
e6/l
0.8
0.5
0.40
117
1096
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
85
848
1.00
0.00
3.1
3.0
e6/l
4.6
2.5
0.68
51
467
(3033799) Differential panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
18.3
—
0
9
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
59.4
—
0
9
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
6.7
—
7.3
—
0
6
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
17.2
—
0
8
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
69
1.01
0.00
2.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
86
0.93
0.00
2.1
2.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
73
0.96
0.00
1.1
2.1
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
58
0.86
0.00
1.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.0
—
84.0
—
0
8
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
59
0.85
0.00
1.0
1.0
—
2.6
—
0
26
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
1.8
—
0
8
(3002523) Influenza virus A Ag [Presence] in Specimen
5
59
0.85
0.00
1.2
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
14.5
—
0
8
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
58
0.86
0.00
1.2
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
59
1.02
0.00
1.0
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
4.0
—
0.5
—
0
6

Mortality – FinRegistry

Association

Association between endpoint H8_PERCHRONDR and mortality.

Females

Parameter HR [95% CI] p-value
H8_PERCHRONDR 1.613 [1.35, 1.93] < 0.001
Birth year 0.994 [0.99, 1.0] 0.2

During the follow-up period (1.1.1998 — 31.12.2019), 337 out of 1198 females with H8_PERCHRONDR died.

Males

Parameter HR [95% CI] p-value
H8_PERCHRONDR 1.223 [1.0, 1.49] 0.046
Birth year 0.985 [0.98, 0.99] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 259 out of 924 males with H8_PERCHRONDR died.

Mortality risk

Mortality risk for people of age

years, who have H8_PERCHRONDR.

N-year risk Females Males
1 0.155% 0.181%
5 1.027% 1.238%
10 2.192% 3.306%
15 4.13% 6.583%
20 7.925% 10.866%

Relationships between endpoints

Index endpoint: H8_PERCHRONDR – Perichondritis of external ear

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data